Merck & Co Inc (NYSE:MRK) shares traded 0.26% higher at $127.99 on Wall Street last session.
MRK stock price is now 2.06% away from the 50-day moving average and 14.35% away from the 200-day moving average. The market capitalization of the company currently stands at $324.15B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $104, Societe Generale recently Downgraded its rating from Hold to Sell for Merck & Co Inc (NYSE: MRK). On January 04, 2024, TD Cowen Upgraded its previous ‘Market Perform’ rating to ‘Outperform’ on the stock increasing its target price from $125 to quote $135, while ‘Deutsche Bank’ rates the stock as ‘Buy’
In other news, Merck & Co., Inc., 10% Owner bought 21,397,205 shares of the company’s stock on Mar 11 ’24. The stock was bought for $492,135,715 at an average price of $23.00. Upon completion of the transaction, the 10% Owner now directly owns 1,000 shares in the company, valued at $0.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 14 ’24, Chairman, CEO & President Davis Robert M sold 85,021 shares of the business’s stock. A total of $10,661,574 was realized by selling the stock at an average price of $125.40. This leaves the insider owning 348,327 shares of the company worth $44.58 million. A total of 0.15% of the company’s stock is owned by insiders.
During the past 12 months, Merck & Co Inc has had a low of $99.14 and a high of $133.10. As of last week, the company has a debt-to-equity ratio of 0.97, a current ratio of 1.25, and a quick ratio of 1.00. According to the stock market information, the enterprise value for the company is $352.12B, which is based on a 968.15 price-to-earnings ratio, a 14.33 price-to-earnings-growth ratio, and a beta of 0.41. The fifty day moving average price for MRK is $125.59 and a two-hundred day moving average price translates $112.01 for the stock.
The latest earnings results from Merck & Co Inc (NYSE: MRK) was released for Dec, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $0.03, beating analysts’ expectations of -$0.11 by 0.14. This compares to $1.18 EPS in the same period last year. The net profit margin was 0.61% and return on equity was 0.87% for MRK. The company reported revenue of $14.63 billion for the quarter, compared to $13.83 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.79 percent. For the current quarter, analysts expect MRK to generate $15.13B in revenue.
